The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care.
ARUP and other clinical labs anxiously await a decision by a federal court in Texas about whether the FDA overstepped its statutory authority.
Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes whole genome sequencing can provide answers and improve cardiac care for all.
February is National Cancer Prevention Month. ARUP Consult provides guidance on hereditary cancer germline genetic testing for early detection and management of inherited cancer syndromes.
A new ARUP white paper highlights the potential indirect costs of outsourcing laboratories and suggests ways for clinical laboratories to demonstrate their value to the health system.
ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.
ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.
ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs.
Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.
ARUP employee Eric Allen started donating blood in 1989 to overcome his fear of blood. Decades later, he has now donated platelets 450 times.
Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.
ARUP medical directors will present key hematopathology research at the 66th ASH Annual Meeting, including developments in systemic mastocytosis treatment and testing for myeloid malignancy mutations.